Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Impact of obesity on live attenuated hepatitis A vaccine response in children and young adults

Termpong Dumrisilp

Background: Obesity predisposes chronic inflammatory state that interferes to vaccine response. There are inconclusive results of correlation between obesity and hepatitis A virus (HAV) vaccine-response. There are limited data focusing on live attenuated hepatitis A vaccine. Objective: Our aim was to evaluate the effect of overweight and obesity on the response to live attenu¬ated hepatitis A vaccine in children and young adult. Methods: This was a prospective cohort study conducted at 3 schools, 1 university and 1 obesity clinic at hospital. The subjects aged 7 to 25 years were tested for baseline anti-HAV antibodies and administered 0.5 mL of live attenu¬ated hepatitis A vaccine (MEVAC-A™). Participants with seronegative defined by anti-HAV antibodies (<20 mIU/mL) were divided into three groups according to obesity defined as follows WHO classification. We evaluated immunogenicity and adverse events (AE) after 8-9 weeks from vaccination. Results: A total of 212 subjects completing the study (female: 131, median age (IQR): 13 years (11-16). Of these, 95 subjects (46%) were in overweight/obesity group. All the AE (n=106) were non-serious and most event was myalgia (34%). The seroprotection (≥20 mIU/mL antibody titer after vaccination) rates were 100 %. Post vaccination geometric mean titers of anti-HAV (IU/L) were 451.1 [95%CI: 374.76-543.0] in underweight group, 428.38 [95%CI: 399.61-459.22] in normal weight group and 467.46 [95%CI: 425.01-514.16] in overweight/obesity group. No significant differences in immunogenicity were found between 3 groups (p=0.33). Conclusion: Live attenu¬ated hepatitis A vaccine is safe and highly immunogenic because all of participants were.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert.